Please see below a list of Dr. Bhatia's external professional relationships and disclosures for the calendar year 2025: 

BOARD MEMBER: Brown University, Ropirio Therapeutics*, Vertex Pharmaceuticals*

ADVISORY ROLES: Amplifyer Bio*, Brigham Research Institute/Brigham and Women’s Hospital, Catalio Capital*, Danaher, Earli Inc.*, Global Oncology, Impilo Therapeutics*, Matrisome Bio*, Ochre Bio*, Port Therapeutics*, Satellite Bio*, Sunbird Bio*, Xilio Therapeutics*

*Dr. Sangeeta Bhatia holds equity in these institutions